This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Ametek (AME) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Ametek (AME) delivered earnings and revenue surprises of 5.84% and 2.32%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Ametek (AME) Moves 3.7% Higher: Will This Strength Last?
by Zacks Equity Research
Ametek (AME) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
AMETEK (AME) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
AMETEK's (AME) third-quarter results are expected to reflect the benefits of acquisitions despite the supply-chain disruptions.
Cognex Corporation (CGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Cognex Corporation (CGNX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ametek (AME) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Ametek (AME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Itron (ITRI) and SmartThings to Enhance Energy Management
by Zacks Equity Research
Itron (ITRI) announces collaboration with SmartThings to enhance energy management and accelerated carbon reduction.
Why Is Ametek (AME) Down 4.8% Since Last Earnings Report?
by Zacks Equity Research
Ametek (AME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights AMETEK, Fortive and National Instruments
by Zacks Equity Research
AMETEK, Fortive and National Instruments have been highlighted in this Industry Outlook article.
3 Testing Equipment Stocks to Overcome Industry Headwinds
by Shilpa Mete
Coronavirus-led disruptions are hurting the Zacks Electronics - Testing Equipment industry. However, industry participants like AME, FTV and NATI are set to gain from 5G prospects.
Jack Henry's (JKHY) Payrailz Buyout to Boost Payment Portfolio
by Zacks Equity Research
Jack Henry (JKHY) inks a deal to acquire the digital payments company Payrailz to expand its payment solutions.
Garmin (GRMN) Aids Automotive Segment Via Tread Audio Systems
by Zacks Equity Research
Garmin (GRMN) introduces the all-in-one Tread Audio System with customizable LED speakers to provide an enhanced audio experience to drivers on the road.
AMETEK (AME) Q2 Earnings & Sales Beat Estimates, Rise Y/Y
by Zacks Equity Research
AMETEK's (AME) second-quarter results reflect solid momentum in the EIG and EMG segments.
Ametek (AME) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Ametek (AME) delivered earnings and revenue surprises of 6.98% and 3.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
AMETEK (AME) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
AMETEK's (AME) second-quarter results are likely to reflect the benefits from acquisitions and growing investments in product development. Yet, impacts of the coronavirus pandemic remain a concern.
National Instruments (NATI) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
National Instruments (NATI) delivered earnings and revenue surprises of 5.88% and 1.79%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Ametek (AME) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Ametek (AME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Itron (ITRI) Moves 5.3% Higher: Will This Strength Last?
by Zacks Equity Research
Itron (ITRI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Why Is Ametek (AME) Down 5.3% Since Last Earnings Report?
by Zacks Equity Research
Ametek (AME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
LYFT Shares Plunge Nearly 30% Since Q1 Earnings Release
by Zacks Equity Research
Despite better-than-expected first-quarter 2022 results owing to increase in Active Riders and Revenue per Active Riders, LYFT provides a bleak second-quarter guidance.
UBER Shares Slip Nearly 5% Despite Q1 Earnings & Revenue Beat
by Zacks Equity Research
UBER's Q1 results benefit from strong performances of the Mobility and Delivery segments, as well as the acquisition of Transplace.
AMETEK (AME) Q1 Earnings Beat Estimates, Sales Rise Y/Y
by Zacks Equity Research
AMETEK's (AME) first-quarter results reflect solid momentum in the EIG and EMG segments.
Ametek (AME) Tops Q1 Earnings Estimates
by Zacks Equity Research
Ametek (AME) delivered earnings and revenue surprises of 4.72% and 0.17%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Itron (ITRI) Tops Q1 Earnings Estimates
by Zacks Equity Research
Itron (ITRI) delivered earnings and revenue surprises of 22.22% and 1.80%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
AMETEK (AME) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
AMETEK's (AME) first-quarter results are expected to reflect the benefits of acquisitions amid the ongoing pandemic.